Replimune Group Inc (NASDAQ: REPL) on Friday, soared 1.86% from the previous trading day, before settling in for the closing price of $10.77. Within the past 52 weeks, REPL’s price has moved between $6.44 and $17.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -14.85% over the past five years. The company achieved an average annual earnings per share of 9.79%. With a float of $62.53 million, this company’s outstanding shares have now reached $77.09 million.
Let’s look at the performance matrix of the company that is accounted for 479 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Replimune Group Inc (REPL) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Replimune Group Inc is 18.88%, while institutional ownership is 93.95%. The most recent insider transaction that took place on May 20 ’25, was worth 260,169. In this transaction Director of this company sold 32,279 shares at a rate of $8.06, taking the stock ownership to the 1,405,071 shares. Before that another transaction happened on May 20 ’25, when Company’s Chief Medical Officer sold 7,952 for $8.06, making the entire transaction worth $64,093. This insider now owns 146,933 shares in total.
Replimune Group Inc (REPL) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 9.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.14% during the next five years compared to -14.85% drop over the previous five years of trading.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Replimune Group Inc (REPL) is currently performing well based on its current performance indicators. A quick ratio of 7.95 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.21, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -1.80 in one year’s time.
Technical Analysis of Replimune Group Inc (REPL)
Replimune Group Inc (NASDAQ: REPL) saw its 5-day average volume 1.99 million, a positive change from its year-to-date volume of 1.03 million. As of the previous 9 days, the stock’s Stochastic %D was 93.21%.
During the past 100 days, Replimune Group Inc’s (REPL) raw stochastic average was set at 54.22%, which indicates a significant decrease from 86.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.59 in the past 14 days, which was lower than the 0.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.15, while its 200-day Moving Average is $11.03. Nevertheless, the first resistance level for the watch stands at $11.29 in the near term. At $11.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.93. If the price goes on to break the first support level at $10.65, it is likely to go to the next support level at $10.33. Assuming the price breaks the second support level, the third support level stands at $10.01.
Replimune Group Inc (NASDAQ: REPL) Key Stats
Market capitalization of the company is 845.64 million based on 77,087K outstanding shares. Right now, sales total 0 K and income totals -247,300 K. The company made 0 K in profit during its latest quarter, and -74,130 K in sales during its previous quarter.
